Video Q&A Series – Pivot Faster – Form
Video Q&A Series
COVID-19 propelled the urgency to rapidly respond to evolving trial requirements and engage in discussions with their CROs to pivot their studies faster.
Pivoting is an imperative. It is also an opportunity for sponsors to fundamentally evolve their technology strategy and leap into the next generation of clinical trials, far beyond COVID-19.
Hear from executives at TissueTech, Rezolute and UroGen Pharma on the pace and performance as they:
- Rapidly virtualize site and patient visits
- Provide a single system for data entry, supply management, and patient monitoring
- Remotely capture and review critical source data
- Seamlessly deploy protocol updates, required due to the pandemic
- Facilitate a quick and easy payment process
With the participation of:
VP of Clinical Operations
Head of Clinical Operations
Business Manager Clinical Development